Occurrence of Comorbidities before and after Soft Tissue Sarcoma Diagnosis
Table 1
Characteristics of newly diagnosed patients with soft tissue sarcoma.
Characteristics
Patients with soft tissue sarcoma ()
N (%)
Gender
Male
266 (50)
Female
267 (50)
Age in years
<50
180 (34)
50–<70
211 (40)
≥70
142 (27)
mean ± SD
56 ()
Location
Extremities
190 (36)
Head and neck
77 (14)
Thorax
97 (18)
Abdomen or (retro)peritoneum
91 (17)
Overlapping sites and NOS
78 (15)
Histology
Fibrosarcoma (ICD-O-3: 8810-4)
17 (3)
Malignant fibrous hystiocytoma
28 (5)
(ICD-O-3: 8830)
Dermatofibrosarcoma
27 (5)
(ICD-O-3: 8832-3)
Liposarcoma (ICD-O-3: 8850-8)
77 (14)
Leiomyosarcoma (ICD-O-3: 8890-1)
84 (16)
Rhabdomyosarcoma
17 (3)
(ICD-O-3: 8900-1, 8910, 8920)
Synovial sarcoma (ICD-O-3: 9040-3)
9 (2)
Hemangiosarcoma (ICD-O-3: 912,
22 (4)
913, 915)
Malignant peripheral nerve sheath
16 (3)
tumor (ICD-O-3: 9540, 9560)
Sarcoma, other
63 (12)
Sarcoma, NOS (ICD-O-3: 8800)
173 (32)
Treatment1,2
Surgery
437 (82)
Chemotherapy
55 (10)
SD: standard deviation; NOS: not otherwise specified; 1no data on radiotherapy available; 2defined during the first six months after soft tissue sarcoma diagnosis.